Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma.
Clinical trial NCT01283542 · COMPLETED
Trial details
- NCT number
- NCT01283542
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-26
- Primary completion
- 2017-09-12
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.